BGI Genomics Co., Ltd. (SHE:300676)
China
· Delayed Price · Currency is CNY 57.76
+7.25 (14.35%)
May 14, 2025, 9:45 AM CST
BGI Genomics Revenue
BGI Genomics had revenue of 671.91M CNY in the quarter ending March 31, 2025, a decrease of -18.18%. This brings the company's revenue in the last twelve months to 3.72B, down -11.82% year-over-year. In the year 2024, BGI Genomics had annual revenue of 3.87B, down -11.10%.
Revenue (ttm)
3.72B
Revenue Growth
-11.82%
P/S Ratio
5.94
Revenue / Employee
1.00M
Employees
3,702
Market Cap
22.06B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.87B | -482.72M | -11.10% |
| Dec 31, 2023 | 4.35B | -2.70B | -38.33% |
| Jan 1, 2023 | 7.05B | 287.01M | 4.24% |
| Jan 1, 2022 | 6.77B | -1.63B | -19.42% |
| Dec 31, 2020 | 8.40B | 5.60B | 199.86% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |